Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BGM Group Ltd. stock logo
BGM
BGM Group
$0.25
-3.1%		$0.28
$0.23
▼
$11.79
$24.40M1.8109,131 shs38,832 shs
OPTH
Optimi Health
$4.95
-0.2%		$4.80
$4.00
▼
$6.40
$28.34MN/A58,386 shs47,183 shs
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
$0.48
-4.4%		$0.49
$0.26
▼
$17.20
$6.29M0.5347,378 shs30,390 shs
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
$2.19
+0.5%		$2.10
$0.99
▼
$2.95
$25.35M0.6532,175 shs7,962 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BGM Group Ltd. stock logo
BGM
BGM Group
-3.09%-4.56%-10.42%-31.23%-97.60%
OPTH
Optimi Health
-0.20%+11.99%+4.65%-1.59%+494,999,900.00%
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
-4.40%-4.00%-4.00%-21.31%-94.06%
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
+0.46%+1.39%+7.88%+12.31%+106.60%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BGM Group Ltd. stock logo
BGM
BGM Group
$0.25
-3.1%		$0.28
$0.23
▼
$11.79
$24.40M1.8109,131 shs38,832 shs
OPTH
Optimi Health
$4.95
-0.2%		$4.80
$4.00
▼
$6.40
$28.34MN/A58,386 shs47,183 shs
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
$0.48
-4.4%		$0.49
$0.26
▼
$17.20
$6.29M0.5347,378 shs30,390 shs
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
$2.19
+0.5%		$2.10
$0.99
▼
$2.95
$25.35M0.6532,175 shs7,962 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BGM Group Ltd. stock logo
BGM
BGM Group
-3.09%-4.56%-10.42%-31.23%-97.60%
OPTH
Optimi Health
-0.20%+11.99%+4.65%-1.59%+494,999,900.00%
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
-4.40%-4.00%-4.00%-21.31%-94.06%
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
+0.46%+1.39%+7.88%+12.31%+106.60%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BGM Group Ltd. stock logo
BGM
BGM Group
1.00
SellN/AN/A
OPTH
Optimi Health
1.50
ReduceN/AN/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
2.20
Hold$53.3311,011.11% Upside
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest RVPH, BGM, OPTH, and TXMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
OPTH
Optimi Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/26/2026
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D-)
8/14/2026
OPTH
Optimi Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/12/2026
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D+)
8/6/2026
BGM Group Ltd. stock logo
BGM
BGM Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D) ➝ Sell (E+)
7/2/2026
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BGM Group Ltd. stock logo
BGM
BGM Group
$37.92M0.64N/AN/A$4.03 per share0.06
OPTH
Optimi Health
$310K91.50N/AN/AN/A∞
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
N/AN/AN/AN/A$1.48 per shareN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
$3.02M8.39$0.05 per share46.94$2.32 per share0.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BGM Group Ltd. stock logo
BGM
BGM Group
-$19.94MN/AN/AN/AN/AN/AN/AN/AN/A
OPTH
Optimi Health
-$1.12M-$0.76N/AN/AN/AN/AN/AN/AN/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
-$19.86M-$1.85N/AN/AN/AN/A-391.58%-119.08%11/12/2026 (Estimated)
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
-$570K$0.02109.50N/AN/A-6.64%-1.09%-0.78%11/17/2026 (Estimated)

Latest RVPH, BGM, OPTH, and TXMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/28/2026Q2 2026
BGM Group Ltd. stock logo
BGM
BGM Group
N/A-$0.01N/A-$0.0050N/A$12.15 million
8/13/2026Q2 2026
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
-$0.3850-$0.19+$0.1950N/AN/AN/A
8/11/2026Q2 2026
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
-$6.1250$0.01+$6.1350$0.01$19.77 million$0.87 million
7/21/2026Q4 2025
BGM Group Ltd. stock logo
BGM
BGM Group
N/A-$2.69N/A-$2.6850N/A$11.80 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BGM Group Ltd. stock logo
BGM
BGM Group
N/AN/AN/AN/AN/A
OPTH
Optimi Health
N/AN/AN/AN/AN/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
N/AN/AN/AN/AN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BGM Group Ltd. stock logo
BGM
BGM Group
N/A
1.25
0.73
OPTH
Optimi Health
0.04
0.06
0.03
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
N/A
2.08
2.08
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
N/A
3.22
3.22

Institutional Ownership

CompanyInstitutional Ownership
BGM Group Ltd. stock logo
BGM
BGM Group
N/A
OPTH
Optimi Health
N/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
63.18%
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
30.74%

Insider Ownership

CompanyInsider Ownership
BGM Group Ltd. stock logo
BGM
BGM Group
58.66%
OPTH
Optimi Health
N/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
8.90%
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
1.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
BGM Group Ltd. stock logo
BGM
BGM Group
47197.22 million40.19 millionN/A
OPTH
Optimi Health
95.73 millionN/AN/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
513.11 million11.67 millionOptionable
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
42011.57 million11.38 millionOptionable

Recent News About These Companies

Critical Contrast: Nutriband (NASDAQ:NTRB) versus TherapeuticsMD (NASDAQ:TXMD)
September 16 at 2:48 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31026012
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains
June 5, 2026  |  marketwatch.comhttps://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-e98194d4-63e529e0f496
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
May 12, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-quarterly-profit-evaluates-strategic-alternatives?utm_source=marketbeat.com&utm_medium=referral
TherapeuticsMD Announces First Quarter 2026 Financial Results
May 12, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260512202804/en/therapeuticsmd-announces-first-quarter-2026-financial-results/
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
April 6, 2026  |  marketwatch.comhttps://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-outperforms-competitors-on-strong-trading-day-040b2196-45a687e58918
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
April 2, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TXMD/pressreleases/1078704/therapeuticsmd-narrows-2025-loss-advances-royalty-strategy/
TherapeuticsMD Explains Brief Delay In Annual Filing
April 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/therapeuticsmd-explains-brief-delay-in-annual-filing?utm_source=marketbeat.com&utm_medium=referral
TherapeuticsMD Announces Full Year 2025 Financial Results
March 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/therapeuticsmd-announces-full-2025-financial-200500867.html
TherapeuticsMD Announces Full Year 2025 Financial Results
March 30, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260330300354/en/therapeuticsmd-announces-full-year-2025-financial-results/
TherapeuticsMD (NASDAQ:TXMD) Director Tommy Thompson Buys 8,400 Shares
December 30, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-txmd-insider-buying-and-selling-2025-12-30/
TherapeuticsMD approves key proposals at annual meeting
December 16, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/therapeuticsmd-approves-key-proposals-at-annual-meeting/ar-AA1Su8Dj
TherapeuticsMD: Q3 Earnings Snapshot
November 13, 2025  |  timesunion.comT
TherapeuticsMD Reports Q3 2025 Financial Results
November 13, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/therapeuticsmd-reports-q3-2025-financial-results/ar-AA1QnC2D
TherapeuticsMD Announces Third Quarter 2025 Financial Results
November 12, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20251112021883/en/therapeuticsmd-announces-third-quarter-2025-financial-results/
TherapeuticsMD Reports Q2 2025 Financial Results
August 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/therapeuticsmd-reports-q2-2025-financial-results/ar-AA1KpHMy
TherapeuticsMD: Q2 Earnings Snapshot
August 12, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/therapeuticsmd-q2-earnings-snapshot-204721737.html
TherapeuticsMD Announces Second Quarter 2025 Financial Results
August 12, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250811851819/en/therapeuticsmd-announces-second-quarter-2025-financial-results/
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors despite daily gains
July 16, 2025  |  marketwatch.comhttps://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-wednesday-when-compared-to-competitors-despite-daily-gains-58f6d45e-3192f8dc9ef2
Marlan D. Walker - TXMD | TherapeuticsMD Inc. - Wall Street Journal
June 29, 2025  |  wsj.comhttps://www.wsj.com/market-data/quotes/TXMD/company-people/executive-profile/120136887
Mayne Pharma Files Legal Complaint Against TherapeuticsMD
June 1, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mayne-pharma-files-legal-complaint-against-therapeuticsmd?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

BGM Group stock logo

BGM Group NASDAQ:BGM

$0.25 -0.01 (-3.09%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.27 +0.02 (+8.76%)
As of 09/18/2026 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Optimi Health NASDAQ:OPTH

$4.95 -0.01 (-0.20%)
As of 09/18/2026 04:00 PM Eastern

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.

Reviva Pharmaceuticals stock logo

Reviva Pharmaceuticals NASDAQ:RVPH

$0.48 -0.02 (-4.40%)
As of 09/18/2026 03:22 PM Eastern

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California.

TherapeuticsMD stock logo

TherapeuticsMD NASDAQ:TXMD

$2.19 +0.01 (+0.46%)
As of 09/18/2026 04:00 PM Eastern

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas